Yaron Naos

Insider Reports History

Location
Carmiel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yaron Naos:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protalix BioTherapeutics, Inc. Sr. VP, Operations Common Stock 225,817 $363,565 $1.61 03 Sep 2025 By Trust
Protalix BioTherapeutics, Inc. Sr. VP, Operations Common Stock 7,112 $11,450 $1.61 03 Sep 2025 Direct
Protalix BioTherapeutics, Inc. Sr. VP, Operations Stock Option (Right to Buy) 50,000 03 Sep 2025 Direct

Insider Reports Filed by Yaron Naos

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLX Protalix BioTherapeutics, Inc. 03 Sep 2025 2 $0 4 Sr. VP, Operations 04 Sep 2025, 17:00
PLX Protalix BioTherapeutics, Inc. 23 Sep 2024 1 $0 4 Sr. VP, Operations 24 Sep 2024, 17:00
PLX Protalix BioTherapeutics, Inc. 15 Aug 2023 1 $0 4 Sr. VP, Operations 17 Aug 2023, 16:30
PLX Protalix BioTherapeutics, Inc. 07 Sep 2022 1 $0 4 Sr. VP, Operations 09 Sep 2022, 17:04